Cure Pharmaceutical (OTCQB: CURR), a Company leveraging its proprietary drug dosage forms and delivery systems to create innovative therapeutics in collaboration with leading biotech and pharmaceutical companies, announced the signing of an exclusive licensing agreement with ReLeaf Europe, a leading European Medicinal Cannabis Company. ReLeaf...
TG Therapeutics (NASDAQ: TGTX), a clinical stage company that is leading the innovation bandwagon in the field of novel therapies for B-cell malignancies and autoimmune diseases has had a great run at the stock market so far this year. Its stocks have almost doubled in 2019 owing...
For anyone having a stroke, time is everything. Getting help quickly can make a difference between recovery and disability. Read more: http://www.aviseanalytics.com/5-promising-stocks-in-the-stroke-management-industry/ Visit: www.aviseanalytics.com...
Hepatitis B Virus Infection affects an estimated 257 million people worldwide and causes 780,000 deaths per year as per a report by World Health Organisation (WHO). In the U.S alone, about 2 percent of the population is living with Hepatitis B or Hepatitis C. It can lead...
An increase in the geriatric population, coupled with a rise in lifestyle diseases such as hypertension, diabetes and coronary cardiac diseases are driving the growth in the stroke diagnostics and therapeutics market not only in the US but in Europe and Asia as well. The market...
